News

In accordance with the study design, all enrolled patients have received their first injection of either Xiaflex or placebo. Due to the high level of interest from patients

A senior healthcare investment banker with over 20 years’ experience in the industry, Mr Crowley will also serve on the company’s audit committee. Mr Crowley retired in 2008

According to the company, lower returns in pharmaceuticals compared to consumer products has led it to revise its strategy. The company has earlier heavily invested in the pharmaceuticals

Medical imaging data collected globally from clinical sites will be delivered to Perceptive Informatics through AG Mednet’s secure, web-enabled network. Through a more efficient image acquisition and collection

This randomized trial compares the treatment of cartilage lesions using BST-CarGel applied following microfracture to treatment with microfracture alone. The trial enrolled subjects aged 18 to 55 years

The company has reported net sales of CHF45.61 billion in 2008, a decrease of 1%, compared to CHF46.13 billion posted in 2007. Operating profit was CHF13.92 billion, a

In this role, Dr Duddu will lead all aspects of the Cephalon drug delivery business at Cima, the company’s wholly owned drug delivery subsidiary located in suburban Minnesota.

Prior to joining Bilcare Global Clinical Supplies (GCS), Mr Moult worked as senior director of clinical trial supplies for UCB (Belgium) where he was also integral to technical

“Our 2008 accomplishments were marked by substantial progress across our product pipeline, in particular by successfully demonstrating the therapeutic potential of SGN-35 and the promise of our antibody-drug